July 7th, 2020 – ViCentra, the company behind Kaleido, the world’s smallest and lightest insulin pump, announced the closing of a €10 million investment round. On June 30, 2020, ViCentra and Invest-NL signed an agreement, with ViCentra being the first investment...
ViCentra announced today that it has appointed Frans Cromme to the role of Chief Executive Officer. ViCentra is home of Kaleido: an innovative and lifestyle focused insulin pump. Frans will lead the continued commercial expansion of the company to various markets...
ViCentra is proud to share that its distribution agreement with Bosman Medical Supplies, part of OneMed, has recently been renewed. The renewal continues the exclusive agreement made in 2017 for the distribution of the Kaleido insulin pump across the Netherlands....
ViCentra is very happy to share that the recently redesigned website for Kaleido, our insulin delivery system, has been named a Platinum winner in the “Web-Based Production: Medical” category at the AVA Digital Awards 2019. The AVA Digital Awards is an international...
The EASD (European Association for the Study of Diabetes) congress is a yearly get together of health care professionals, researchers, businesses and members of the diabetes online community. Research results are presented, there’s time to catch up with acquaintances...
Following a successful pilot scheme at a small selection Dutch hospitals, Kaleido has now fully launched in the Netherlands. As the company behind the smallest and lightest insulin pump in the world, at ViCentra we’re proud to announce that our first Kaleidoers...
Recent Comments